New Delhi, Apr 23: The Union health ministry on Thursday issued a revised ''Clinical Guidance for Management of Adult COVID-19 Patients'' recommending the EUA/off-label use of Tocilizumab drug in case of severe diseases, preferably within 24 to 48 hours of the